Loading
Tachykinin receptor blockers have the potential to treat stress-induced anxiety and aggression, but economic barriers hinder their clinical development.
“I remain convinced that this family of drugs could have very powerful uses in treating some forms of stress-induced anxiety or aggressiveness in humans, but it's just very difficult, for economic reasons, to find a way to get somebody to test that.”
Huberman Lab · Sep 2022 · 1 episode · 222K views on this topicExtracted by a model; may misattribute who said what.